For FDA-approved tirzepatide, LillyDirect Zepbound vials at ~$499/mo self-pay is the manufacturer-direct benchmark
Your provider can help you decide whether a maintenance dose, a trial pause, or indefinite continuation best fits your health goals and weight-loss history
There were also no differences in metabolic glucose clearance, alanine turnover, urea synthesis and glucose formation by gluconeogenesis using alanine as precursor
Tong K, Yin S, Yu Y, et al
The secondary outcomes were all-cause death, heart failure admission, admission due to any cause, composite major adverse limb events including newly diagnosed peripheral arterial disease, claudication, clinical limb ischemia, limb revascularization or amputation, hypoglycemia, diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), and infection death
Key Points for Practice To reduce overall mortality in patients with type 2 diabetes mellitus, the BMJ/MAGIC Group recommends prescribing SGLT-2 inhibitors in those with cardiovascular disease and/or chronic kidney disease or three or more risk factors for cardiovascular disease
